SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    I. Mendel, E. Feige, N. Yacov, Y. Salem, I. Levi, O. Propheta-Meiran, A. Shoham, E. Ishai, J. George, D. Harats, E. Breitbart, VB-201, an oxidized phospholipid small molecule, inhibits CD14- and Toll-like receptor-2-dependent innate cell activation and constrains atherosclerosis, Clinical & Experimental Immunology, 2014, 175, 1
  2. 2
    Ulrich Matt, Omar Sharif, Rui Martins, Tanja Furtner, Lorene Langeberg, Riem Gawish, Immanuel Elbau, Ana Zivkovic, Karin Lakovits, Olga Oskolkova, Bianca Doninger, Andreas Vychytil, Thomas Perkmann, Gernot Schabbauer, Christoph J. Binder, Valery N. Bochkov, John D. Scott, Sylvia Knapp, WAVE1 mediates suppression of phagocytosis by phospholipid-derived DAMPs, Journal of Clinical Investigation, 2013, 123, 7, 3014

    CrossRef

  3. 3
    Valery N. Bochkov, Olga V. Oskolkova, Konstantin G. Birukov, Anna-Liisa Levonen, Christoph J. Binder, Johannes Stöckl, Generation and Biological Activities of Oxidized Phospholipids, Antioxidants & Redox Signaling, 2010, 12, 8, 1009

    CrossRef

  4. 4
    Erez Feige, Itzhak Mendel, Jacob George, Niva Yacov, Dror Harats, Modified phospholipids as anti-inflammatory compounds, Current Opinion in Lipidology, 2010, 21, 6, 525

    CrossRef

  5. You have free access to this content5
    Magdalena Paolino, Josef M. Penninger, E3 ubiquitin ligases in T-cell tolerance, European Journal of Immunology, 2009, 39, 9
  6. 6
    Lucia S. Graham, Farhad Parhami, Yin Tintut, Christina M.R. Kitchen, Linda L. Demer, Rita B. Effros, Oxidized lipids enhance RANKL production by T lymphocytes: Implications for lipid-induced bone loss, Clinical Immunology, 2009, 133, 2, 265

    CrossRef